Hyperion DeFi (NASDAQ:HYPD) Announces Quarterly Earnings Results

Posted by Geri Gentry on Aug 12th, 2026

Hyperion DeFi (NASDAQ:HYPD – Get Free Report) issued its earnings results on Wednesday. The company reported $0.92 earnings per share for the quarter, Zacks reports.

Hyperion DeFi Stock Up 1.9%

Shares of HYPD traded up $0.05 during trading hours on Wednesday, hitting $2.69. The company had a trading volume of 121,860 shares, compared to its average volume of 436,417. The company has a current ratio of 1.97, a quick ratio of 1.97 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $40.78 million, a PE ratio of -0.27 and a beta of 2.53. Hyperion DeFi has a one year low of $2.34 and a one year high of $15.00. The company’s fifty day moving average price is $2.94 and its two-hundred day moving average price is $3.36.

Wall Street Analyst Weigh In

HYPD has been the topic of a number of recent research reports. Cantor Fitzgerald increased their price target on Hyperion DeFi from $4.00 to $6.60 and gave the stock an “overweight” rating in a research report on Wednesday, July 1st. Weiss Ratings raised shares of Hyperion DeFi from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, June 24th. Zacks Research upgraded shares of Hyperion DeFi from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 14th. Finally, Chardan Capital restated a “buy” rating and issued a $7.30 price target on shares of Hyperion DeFi in a report on Tuesday. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Hyperion DeFi presently has a consensus rating of “Hold” and a consensus target price of $6.95.

Get Our Latest Report on HYPD

Insiders Place Their Bets

In related news, insider Hyunsu Jung bought 7,000 shares of the business’s stock in a transaction on Monday, June 1st. The shares were bought at an average price of $3.70 per share, for a total transaction of $25,900.00. Following the completion of the purchase, the insider directly owned 1,384,676 shares of the company’s stock, valued at approximately $5,123,301.20. This trade represents a 0.51% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 7.50% of the stock is currently owned by insiders.

Institutional Trading of Hyperion DeFi

Several hedge funds have recently modified their holdings of HYPD. Price T Rowe Associates Inc. MD purchased a new position in Hyperion DeFi in the fourth quarter worth $73,000. State Street Corp purchased a new stake in shares of Hyperion DeFi during the 4th quarter valued at $92,000. Geode Capital Management LLC purchased a new stake in shares of Hyperion DeFi during the 4th quarter valued at $214,000. Focus Partners Advisor Solutions LLC acquired a new stake in shares of Hyperion DeFi in the 4th quarter worth $221,000. Finally, Jane Street Group LLC acquired a new stake in shares of Hyperion DeFi in the 4th quarter worth $493,000. 25.84% of the stock is owned by hedge funds and other institutional investors.

About Hyperion DeFi

(Get Free Report)

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.